Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -178,931 | -132,996 | -89,953 | -46,892 | -299,964 |
| Depreciation Amortization | 2,946 | 2,345 | 1,603 | 783 | 3,014 |
| Accounts receivable | -1,784 | -3,014 | -5,397 | -2,561 | -6,699 |
| Accounts payable and accrued liabilities | 5,319 | -250 | 3,136 | 4,685 | 833 |
| Other Working Capital | -31,648 | -29,327 | -37,958 | -20,720 | 820 |
| Other Operating Activity | 51,236 | 45,538 | 31,693 | 13,353 | 61,172 |
| Operating Cash Flow | $-152,862 | $-117,704 | $-96,876 | $-51,352 | $-240,824 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -33,468 | -49,753 | -44,255 | 59,652 | 182,818 |
| PPE Investments | -841 | -860 | -287 | N/A | -1,970 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,000 |
| Investing Cash Flow | $-34,309 | $-50,613 | $-44,542 | $59,652 | $176,848 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 165,419 | 164,941 | 164,732 | 83 | 14,930 |
| Other Financing Activity | -425 | -425 | -425 | 0 | -40 |
| Financing Cash Flow | $164,994 | $164,516 | $164,307 | $83 | $14,890 |
| Exchange Rate Effect | -145 | -724 | -254 | -114 | 252 |
| Beginning Cash Position | 87,063 | 87,063 | 87,063 | 87,063 | 135,897 |
| End Cash Position | 64,741 | 82,538 | 109,698 | 95,332 | 87,063 |
| Net Cash Flow | $-22,322 | $-4,525 | $22,635 | $8,269 | $-48,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -152,862 | -117,704 | -96,876 | -51,352 | -240,824 |
| Capital Expenditure | -841 | -860 | -287 | 0 | -1,970 |
| Free Cash Flow | -153,703 | -118,564 | -97,163 | -51,352 | -242,794 |